Last Updated on November 20, 2024 by The Health Master
Medical Device
In a significant move to bolster India’s medical device industry, the Union Ministry of Chemicals and Fertilizers has unveiled a new scheme worth Rs 500 crore.
This initiative, spanning three years from 2024-25 to 2026-27, aims to propel the sector’s growth and reduce reliance on imports.
A Comprehensive Approach
The scheme is a holistic endeavor that addresses multiple facets of the medical device industry.
Key areas of focus include:
- Manufacturing of Critical Components and Accessories: Encouraging domestic production of essential medical device components.
- Skill Development: Upgrading the skills of the workforce to meet industry standards.
- Clinical Studies Support: Facilitating the conduct of clinical trials to validate the efficacy of medical devices.
- Common Infrastructure Development: Creating shared facilities to foster innovation and collaboration.
- Industry Promotion: Undertaking promotional activities to enhance the visibility of Indian medical devices globally.
Govt’s Commitment to Self-Reliance
Union Minister for Chemicals and Fertilizers, J P Nadda, emphasized the government’s dedication to strengthening the medical device sector.
He described the new scheme as a “game-changer” that will drive significant transformation.
Nadda highlighted the vision of making India a global leader in the medical device industry.
By reducing import dependency and fostering self-reliance, the government aims to contribute to the realization of the “Viksit Bharat@2047” goal.
Key Components of the Scheme
The scheme is divided into five sub-schemes:
- Common Facilities for Medical Devices Clusters: Allocating Rs 110 crore to establish shared infrastructure for medical device manufacturers.
- Marginal Investment Scheme: Investing Rs 180 crore to incentivize domestic manufacturing and reduce import dependence.
- Capacity Building and Skill Development: Dedicating Rs 100 crore to enhance the skills of medical device professionals.
- Medical Device Clinical Studies Support Scheme: Providing Rs 100 crore to support clinical trials and regulatory approvals.
- Medical Device Promotion Scheme: Allocating Rs 10 crore to promote Indian medical devices in domestic and international markets.
A Thriving Medical Device Ecosystem
India’s medical device market is poised for exponential growth, with an estimated value of $11 billion and projected to reach $50 billion by 2025.
The sector has been witnessing a robust CAGR of 15% over the past three years.
The country boasts a vibrant ecosystem of 750-800 domestic medical device manufacturers, who contribute significantly to the domestic market.
Additionally, over 250 startups are actively engaged in innovative solutions for addressing critical healthcare challenges.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Procedure to obtain license for manufacturing of Medical Devices
Procedure for registration of Medical Devices: CDSCO
Qualification and Experience: For Technical Staff in Medical Devices
Registration for sale of Medical Devices: Procedure and conditions
Latest Notifications: Medical Devices
Classifications of Medical Devices under the provisions of MDR 2017
Notified Bodies for Medical Devices
Updated list of Notified Bodies for Medical Devices
Updated list of Medical Device Testing Laboratories (MDTLs)
Forms: All types of Medical Devices
Schedules: All types of Medical Devices
Govt to amend MDR to include QMS requirements for Class A Medical Devices
New Drugs, Medical Devices and Global Standards: India’s Regulatory Advancements
MvPI Releases Updated Medical Device Adverse Event Reporting Form
CDSCO Gains Global Recognition: Milestone for Indian Medical Device Industry
Key components of Uniform Code for Marketing Practices in Medical Devices (UCMPMD) 2024
Govt issues new uniform code for marketing of Medical Devices
Pharma Company faces regulatory action after investigation: HP
Fire Safety in Pharma Industry: A Call for Urgent Action
USFDA proposes Ban on Phenylephrine present in cold medicines
Pharma Water Systems: A Digital Revolution
NPPA’s Price Cap on Dobustat 250 mg Injection Upheld
Anti dumping probe on Calcium Carbonate
Delhi Court orders Permanent Injunction in a Trademark case
CDSCO to implement stricter regulations for health supplements
